 Xenon Pharmaceuticals Inc NASDAQ: XENE priced its underwritten public offering of 8.5 million shares and pre-funded warrants to purchase up to 1.7 million shares. The common share offer price of 29.50 represents a marginal discount of 1.6 over the last close price of 29.99 on Tuesday. 